Clinical trial

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

NCT03004612

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

COMBINATION_PRODUCT · Unmapped registry intervention Linagliptin + metformin Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Metformin Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-01-01

PhasePHASE4

Conditions

Prediabetic Stateunresolved

Insulin Resistanceunresolved

Interventions

Linagliptin + metforminCOMBINATION_PRODUCT

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Universidad de Guanajuatolead sponsor

Hospital Regional de Alta Especialidad del Bajiocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03004612 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.